Analysis of Antithyroid Drug-Induced Severe Liver Injury in 18,558 Newly Diagnosed Patients with Graves' Disease in Japan.
暂无分享,去创建一个
K. Sugino | Miho Suzuki | J. Noh | M. Matsumoto | Akiko Kawaguchi | Yo Kunii | N. Watanabe | H. Ohye | A. Yoshihara | Kenji Iwaku | K. Ito | Nami Suzuki | Mitsuha Morisaki | Marino Hiruma
[1] Jun Zhang,et al. Analysis of 90 cases of antithyroid drug-induced severe hepatotoxicity over 13 years in China. , 2015, Thyroid : official journal of the American Thyroid Association.
[2] J. Kung,et al. Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity , 2014, Expert opinion on drug safety.
[3] C. Hsieh,et al. Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study. , 2014, British journal of clinical pharmacology.
[4] ItoKoichi,et al. Characteristics of agranulocytosis as an adverse effect of antithyroid drugs in the second or later course of treatment. , 2014 .
[5] S. Nishikawa,et al. Th2 cytokine‐mediated methimazole‐induced acute liver injury in mice , 2012, Journal of applied toxicology : JAT.
[6] M. Kami,et al. Antithyroid drug-induced hematopoietic damage: a retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with Graves' disease. , 2012, The Journal of clinical endocrinology and metabolism.
[7] S. Rivkees,et al. Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children. , 2010, The Journal of clinical endocrinology and metabolism.
[8] Kunihiko Ito,et al. Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs. , 2009, The Journal of clinical endocrinology and metabolism.
[9] S. Rivkees,et al. Putting propylthiouracil in perspective. , 2009, The Journal of clinical endocrinology and metabolism.
[10] K. Tajiri,et al. Practical guidelines for diagnosis and early management of drug-induced liver injury. , 2008, World journal of gastroenterology.
[11] A. Miyauchi,et al. Serial changes in liver function tests in patients with thyrotoxicosis induced by Graves' disease and painless thyroiditis. , 2008, Thyroid : official journal of the American Thyroid Association.
[12] Ashok Kumar,et al. Hyperthyroidism induces apoptosis in rat liver through activation of death receptor-mediated pathways. , 2007, Journal of hepatology.
[13] J. Castell,et al. Allergic hepatitis induced by drugs , 2006, Current opinion in allergy and clinical immunology.
[14] P. Watkins,et al. Liver transplantation for acute liver failure from drug induced liver injury in the United States , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[15] Ashok Kumar,et al. Severe hyperthyroidism induces mitochondria‐mediated apoptosis in rat liver , 2004, Hepatology.
[16] J. Ruiz,et al. Fulminant Hepatic Failure Associated with Propylthiouracil , 2003, The Annals of pharmacotherapy.
[17] S. Dong,et al. The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study , 2001, American Journal of Gastroenterology.
[18] H. Pantazi,et al. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism. , 2000, The Journal of clinical endocrinology and metabolism.
[19] J. Reyes,et al. Fifty years of experience with propylthiouracil-associated hepatotoxicity: what have we learned? , 1997, The Journal of clinical endocrinology and metabolism.
[20] Y. Liaw,et al. Clinical associations between thyroid and liver diseases , 1995, Journal of gastroenterology and hepatology.
[21] Y. Liaw,et al. Hepatic Injury during Propylthiouracil Therapy in Patients with Hyperthyroidism: A Cohort Study , 1993, Annals of Internal Medicine.
[22] R. A. Neal,et al. Inhibition of hepatic mixed-function oxidase activity in vitro and in vivo by various thiono-sulfur-containing compounds. , 1975, Biochemical pharmacology.